34. The Role of the Microbiome in Development and Maintenance of Immunity
Friday, October 21, 2011: 8:45 AM-10:15 AM
Room: 204AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the known causal associations between specific members of the intestinal microbiome and differentiation of cellular immune responses
  • explain the mechanisms of the effects of broad-spectrum antibiotic therapy on susceptibility to colonization and disease by vancomycin-resistant Enterococci and by Clostridium difficile
  • integrate knowledge of the influence of the microbiome on immunity to promote understanding of the roles of antimicrobial utilization
  • discuss the contributions of specific intestinal bacteria to development of immunity and control of inflammation

Target Audience: physicians interested in C. difficile and vancomycin-resistant Enterococci, physicians and investigators interested in pathogenesis of inflammatory bowel disease, Vaccinologists, Scientists, Researchers, Pharmacists, Microbiologists, Lab Personnel, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Fellows-in-Training, Clinicians, Academicians

Tracks: Global ID, Investigative ID, HIV, Pediatric ID, Adult ID

Moderators:  Joel Ernst, MD, FIDSA, New York University School of Medicine and Eric Pamer, MD, FIDSA, Memorial Sloan Kettering Cancer Center

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-123-L01-P


J. Ernst, None

E. Pamer, None

E. Pamer, None

K. Cadwell, None

W. S. Garrett, Danone Research: Grant Investigator, Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.